A clinical study of 15 cases of primary carcinoma of the fallopian tube.
- Author:
Hyun Jung LEE
1
;
Keum Jung LEE
;
Min Ji KIM
;
Back Kyung SEO
;
Young YU
;
Kyung Taek LIM
;
Seok Ju SEONG
;
Tae Jin KIM
;
Chong Taik PARK
;
Jae Uk SHIM
;
Ki Heon LEE
Author Information
1. Department of Obstetrics and Gynecology, Samsung Cheil Hospital and Women's Healthcare Center, College of Medicine, Sungkyunkwan University, Seoul, Korea. oncolim.lim@samsung.com
- Publication Type:Original Article
- Keywords:
Fallopian tube malignancies;
Management;
Survival
- MeSH:
Chemotherapy, Adjuvant;
Diagnosis;
Fallopian Tubes*;
Female;
Follow-Up Studies;
Humans;
Laparotomy;
Radiotherapy, Adjuvant;
Retrospective Studies;
Uterine Hemorrhage
- From:Korean Journal of Gynecologic Oncology
2005;16(4):354-360
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: The aim of the study is to determine the clinical characteristics and management of primary fallopian tube malignancies together with the results there unto that had been diagnosed and treated in Samsung Cheil Hospital oncology department retrospectively. METHODS: The fifteen cases of fallopian tube malignancies, of a total of 3495 gynecologic malignancies (0.043%) that has been diagnosed in or referred to our hospital between January 1993 and December 2004 were evaluated retrospectively. We investigate the clinicopathologic findings and analyze the survival period for 15 patients with primary fallpian tube malignancies who were surgically operated. RESULTS: The mean age of patients is 53.47 years. Most frequent application symptoms of the cases are pelvic mass (46.7%) and abnormal uterine bleeding (40%). The staging laparotomy was done in 12 patients. According to FIGO staging, seven of the cases are stage I, six of the cases are stage III, and one of the cases is borderline malignancy. Adjuvant chemotherapy was applied 13 cases and adjuvant radiotherapy was applied one case. Mean follow up period of the cases is 27.8 months. CONCLUSION: Primary fallopian tube malignancies are very rare malignancies. Diagnosis can be made generally peri or postoperatively. More extensive clinical research must be performed in order to have definite etiologic diagnostic management modalities and prognostic markers.
